<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01599637</url>
  </required_header>
  <id_info>
    <org_study_id>CIGE025E2201</org_study_id>
    <secondary_id>2011-004216-31</secondary_id>
    <nct_id>NCT01599637</nct_id>
  </id_info>
  <brief_title>Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment</brief_title>
  <official_title>A Phase II, Multi-centre, Randomized, Double Blind, Placebo-controlled Study to Determine the Mode of Action of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      The study is designed to explore the mode of action for omalizumab therapy in patients with
      chronic idiopathic urticaria.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Observed Values and Absolute Change From Baseline in FceRI Positive Skin Cells: Dermis, Lesional and Non Lesional Skin</measure>
    <time_frame>Baseline through Day 85 post-treatment</time_frame>
    <description>Observed values and absolute change in FcεRI positive skin cells: dermis non-lesional and lesional. The primary variable for this study was the relative change from baseline in the high affinity IgE receptor (FcεRI) positive skin cells, based on skin biopsies collected from patients with CIU after 12 weeks of treatment.The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Values and Absolute Change From Baseline in IgE Positive Skin Cells: Dermis, Lesional and Non Lesional Skin</measure>
    <time_frame>Baseline through Day 85 post-treatment</time_frame>
    <description>Observed values and absolute change in IgE positive skin cells: dermis non-lesional and lesional The primary variable for this study was the relative change from baseline in IgE positive skin cells, based on skin biopsies collected from patients with CIU after 12 weeks of treatment. The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of Change From Baseline in IgE Receptor FceRI With Change From Baseline in UAS7 at Week 12 by Treatment, Skin Layer and Lesion Status</measure>
    <time_frame>Baseline through Day 85</time_frame>
    <description>Correlation of primary endpoint with The UAS7 which is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of Change From Baseline in IgE on Positive Skin Cells With Change From Baseline in UAS7 at Week 12 by Treatment, Skin Layer and Lesion Status</measure>
    <time_frame>Baseline through Day 85</time_frame>
    <description>Correlation of primary endpoint with The UAS7 which is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observed Values and Absolute Change From Baseline in Skin Cell Subsets (CD3, CD4, CD8, Eosinophils, DCs, and Mast Cells) by Parameter, Skin Layer, Lesion Status, Treatment and Visit</measure>
    <time_frame>Baseline to Day 85</time_frame>
    <description>The average number of cells derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observed Values From Baseline Through End of Study of Serum Chemkines or Histamine in Peripheral Blood Cells by Parameter, Treatment and Visit</measure>
    <time_frame>Baseline through Day 85</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observed Values and Change From Baseline in Peripheral Blood Cell Subsets (FACS Parameters) at Week 12 (Day 85) by Treatment (PD Analysis Set) Measured as % Out of Leukocytes.</measure>
    <time_frame>Baseline through Day 85</time_frame>
    <description>Fluorescence-activated cell sorting (FACS) is a specialized type of flow cytometry that provides a method for sorting a heterogeneous mixture of biological cells into two or more containers, one cell at a time, based upon the specific light scattering and fluorescent characteristics of each cell. (FACS) provides fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. A wide range of fluorophores can be used as labels in flow cytometry. Fluorophores are typically attached to an antibody that recognizes a target feature on or in the cell; they may also be attached to a chemical entity with affinity for the cell membrane or another cellular structure. Each fluorophore has a characteristic peak excitation and emission wavelength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observed Values and Change From Baseline in Peripheral Blood Cell Subsets (FACS Parameters) at Week 12 (Day 85) by Treatment (PD Analysis Set) Measured in Fluorescence Units.</measure>
    <time_frame>Baseline through Day 85</time_frame>
    <description>Fluorescence-activated cell sorting (FACS) is a specialized type of flow cytometry that provides a method for sorting a heterogeneous mixture of biological cells into two or more containers, one cell at a time, based upon the specific light scattering and fluorescent characteristics of each cell. (FACS) provides fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. A wide range of fluorophores can be used as labels in flow cytometry. Fluorophores are typically attached to an antibody that recognizes a target feature on or in the cell; they may also be attached to a chemical entity with affinity for the cell membrane or another cellular structure. Each fluorophore has a characteristic peak excitation and emission wavelength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Baseline PD Parameters Between Healthy Volunteers and Urticaria Patients by Skin Layer Pharmacodynamic Analysis Set</measure>
    <time_frame>Baseline</time_frame>
    <description>The # positive cell values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Levels of Omalizumab</measure>
    <time_frame>Baseline through Day 85</time_frame>
    <description>Serum concentrations (ng/mL) of omalizumab by visit after the administration of omalizumab 300 mg every 4 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean (SD) Serum Total IgE Concentration From Baseline by Visit</measure>
    <time_frame>Baseline through Day 85</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean (SD) Serum Total IgE % Change From Baseline by Visit</measure>
    <time_frame>Baseline through Day 85</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean (SD) Serum Free IgE Concentration From Baseline by Visit</measure>
    <time_frame>Baseline through Day 85</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean (SD) Serum Free IgE % Change From Baseline by Visit</measure>
    <time_frame>Baseline through Day 85</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Summary Statistics of Observed Values and Absolute Change From Baseline in Specific IgE Against Allergens and Bacterial Antigens by Parameter, Treatment and Visit</measure>
    <time_frame>Baseline through Day 140</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Urticaria Activity Score (UAS7)</measure>
    <time_frame>Baseline, Day 85</time_frame>
    <description>Efficacy was assessed by the urticaria activity score (UAS). UAS was completed each morning and evening on a daily basis to record patient symptoms of itch and hives via an electronic diary. The UAS is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease. A negative change score (Week 12 score minus Baseline score) indicates improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Likert Scale-Physician's and Patients In-clinic Global Assessment by Treatment</measure>
    <time_frame>Baseline, Day 85</time_frame>
    <description>The investigator or the person he or she designated and the patient provided scoring of the patient's global assessment of symptoms (urticaria lesions (hives) and pruritus) reflective of the patient's condition over the 12 hours prior to the visit (0 = no symptoms, 1 = mild, 2 = moderate 3 = severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Angioedema-free Days Weeks 4 Through 12 by Treatment</measure>
    <time_frame>Day 29 to Day 85</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Dermatology Life Quality Index (DLQI) by Treatment</measure>
    <time_frame>Baseline through Day 85</time_frame>
    <description>The DLQI is a 10-item dermatology-specific health-related quality of life measure. Patients rated their dermatology symptoms as well as the impact of their skin condition on various aspects of their lives. An overall score was calculated as well as for the following domains: Symptoms and Feelings, Daily Activities, Leisure, Work and School, Personal Relationships, Treatment.Negative score shows positive efficacy. Meaning of DLQI Scores 0-1 = no effect at all on patient's life 2-5 = small effect on patient's life 6-10 = moderate effect on patient's life 11-20 = very large effect on patient's life 21-30 = extremely large effect on patient's life. The DLQI is calculated by summing the score of each question resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired. The DLQI can also be expressed as a percentage of the maximum possible score of 30.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skindex-29 by Treatment</measure>
    <time_frame>Baseline and Day 85</time_frame>
    <description>The Skindex-29 is a validated 29-item instrument to measure the effects of skin disease on patients' quality of life.Results are reported as 3 scale scores (functioning, emotions and symptoms) and a composite score (average scale score). The domain scores and the overall score are expressed on a 100-point scale, with higher scores indicating a lower level of quality of life. The cuttoff values for each category are noted below. Symtoms; 39 mild, 42 moderate,52 severe. Emotions; 24 mild, 35 moderate, 39 severe. Functioning: 21 mild, 32 moderate, 37 severe. Overal Score: 25 mild, 32 moderate, 44 severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Urticaria Quality of Life Questionnaire (Cu-Q2OL) by Treatment</measure>
    <time_frame>Baseline and Day 85</time_frame>
    <description>The Cu-Q2OL is a 23-item CIU-specific health-related quality of life questionnaire. Patients rated their CIU symptoms and the impact of their CIU on various aspects of their lives. An overall score was calculated as well for the following domains: pruritus, swelling, impact on life activities, sleep problems, limits, and looks. Zero is the minmum score and 100 the maximum score. The higher score correlates to more disease activity.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Chronic Idiopathic Urticaria</condition>
  <arm_group>
    <arm_group_label>IGE025</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive omalizumab administered subcutaneously every 4 weeks at the study center.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo to IGE025</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo administered subcutaneously every 4 weeks at the study center.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IGE025</intervention_name>
    <description>Study medication will be supplied as a lyophilized, sterile powder in a single-use, 5-mL vial.</description>
    <arm_group_label>IGE025</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Study medication will be supplied as a lyophilized, sterile powder in a single-use, 5-mL vial.</description>
    <arm_group_label>Placebo to IGE025</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of chronic spontaneous urticaria refractory to H1 antihistamines at Baseline

        Exclusion Criteria:

          -  Clearly defined underlying etiology for chronic urticarias other than CIU (main
             manifestation being physical urticaria). This includes the following urticarias:
             Acute, solar, cholinergic, heat, cold, aquagenic, delayed pressure or contact, as well
             as the following diseases as these diseases may have symptoms of urticaria or
             angioedema: Urticarial vasculitis, urticaria pigmentosa, erythema multiforme,
             mastocytosis, hereditary or acquired angioedema, lymphoma, leukemia, or generalized
             cancer.

          -  Previous treatment with omalizumab.

          -  A history or presence of atopic dermatitis, bullous pemphigoid, dermatitis
             herpetiformis, senile pruritus or other skin disease associated with itch.

        Other protocol-defined inclusion/exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Muenster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2012</study_first_submitted>
  <study_first_submitted_qc>May 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2012</study_first_posted>
  <results_first_submitted>September 10, 2014</results_first_submitted>
  <results_first_submitted_qc>October 30, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 3, 2014</results_first_posted>
  <last_update_submitted>March 11, 2015</last_update_submitted>
  <last_update_submitted_qc>March 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic idiopathic urticaria</keyword>
  <keyword>CIU</keyword>
  <keyword>Xolair</keyword>
  <keyword>IGE025</keyword>
  <keyword>FcεRI</keyword>
  <keyword>IgE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urticaria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Omalizumab</mesh_term>
    <mesh_term>Histamine Antagonists</mesh_term>
    <mesh_term>Histamine H1 Antagonists</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IGE025</title>
          <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
        </group>
        <group group_id="P2">
          <title>Placebo to IGE025</title>
          <description>Placebo administered subcutaneously every 4 weeks at the study center.</description>
        </group>
        <group group_id="P3">
          <title>Healthy Volunteers</title>
          <description>Healthy volunteer data was collected at baseline only. These healthy volunteers did not receive any test treatment. The data collected from these individuals was used to provide a reference to help characterize the levels of skin biopsy markers and were used in the descriptive analyses but not formally compared with the corresponding levels in the treated subjects</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20">&quot; started&quot; indicates randomized safety, pharmacodynamics and pharmocokinetics set</participants>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>administrative problems</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IGE025</title>
          <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
        </group>
        <group group_id="B2">
          <title>Placebo to IGE025</title>
          <description>Placebo administered subcutaneously every 4 weeks at the study center.</description>
        </group>
        <group group_id="B3">
          <title>Healthy Volunteers</title>
          <description>Healthy volunteer data was collected at baseline only. These healthy volunteers did not receive any test treatment. The data collected from these individuals was used to provide a reference to help characterize the levels of skin biopsy markers and were used in the descriptive analyses but not formally compared with the corresponding levels in the treated subjects</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.5" spread="11.02"/>
                    <measurement group_id="B2" value="41.1" spread="7.96"/>
                    <measurement group_id="B3" value="36.4" spread="9.74"/>
                    <measurement group_id="B4" value="38.7" spread="10.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Observed Values and Absolute Change From Baseline in FceRI Positive Skin Cells: Dermis, Lesional and Non Lesional Skin</title>
        <description>Observed values and absolute change in FcεRI positive skin cells: dermis non-lesional and lesional. The primary variable for this study was the relative change from baseline in the high affinity IgE receptor (FcεRI) positive skin cells, based on skin biopsies collected from patients with CIU after 12 weeks of treatment.The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
        <time_frame>Baseline through Day 85 post-treatment</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis. Patients with both baseline and week 12 data were included in this analysis</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Values and Absolute Change From Baseline in FceRI Positive Skin Cells: Dermis, Lesional and Non Lesional Skin</title>
          <description>Observed values and absolute change in FcεRI positive skin cells: dermis non-lesional and lesional. The primary variable for this study was the relative change from baseline in the high affinity IgE receptor (FcεRI) positive skin cells, based on skin biopsies collected from patients with CIU after 12 weeks of treatment.The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis. Patients with both baseline and week 12 data were included in this analysis</population>
          <units>FcεRI positive skin cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>FcεRI +ve skin cells: dermis lesional D1 (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.14" spread="7.08"/>
                    <measurement group_id="O2" value="15.17" spread="3.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FcεRI +ve skin cells: dermis lesional d85 (n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.40" spread="5.88"/>
                    <measurement group_id="O2" value="20.19" spread="8.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FcεRI +ve skin cells:dermis lesional Chge(n=10,6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.42" spread="7.42"/>
                    <measurement group_id="O2" value="3.69" spread="10.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FcεRI +ve skincells:dermis nonlesional D1(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.91" spread="9.42"/>
                    <measurement group_id="O2" value="20.48" spread="5.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FcεRI +ve skincells:dermis nonlesional D85(n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.72" spread="7.56"/>
                    <measurement group_id="O2" value="20.81" spread="7.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FcεRI +ve skincells:dermis nonlesional Chg(n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.40" spread="9.06"/>
                    <measurement group_id="O2" value="-0.07" spread="9.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Observed Values and Absolute Change From Baseline in IgE Positive Skin Cells: Dermis, Lesional and Non Lesional Skin</title>
        <description>Observed values and absolute change in IgE positive skin cells: dermis non-lesional and lesional The primary variable for this study was the relative change from baseline in IgE positive skin cells, based on skin biopsies collected from patients with CIU after 12 weeks of treatment. The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
        <time_frame>Baseline through Day 85 post-treatment</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis. Patients with both baseline and week 12 data were included in this analysis</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Values and Absolute Change From Baseline in IgE Positive Skin Cells: Dermis, Lesional and Non Lesional Skin</title>
          <description>Observed values and absolute change in IgE positive skin cells: dermis non-lesional and lesional The primary variable for this study was the relative change from baseline in IgE positive skin cells, based on skin biopsies collected from patients with CIU after 12 weeks of treatment. The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis. Patients with both baseline and week 12 data were included in this analysis</population>
          <units>IgE positive skin cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IgE positive cells, lesional D1 (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.93" spread="8.61"/>
                    <measurement group_id="O2" value="15.23" spread="15.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE positive cells, lesional D85 (n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.73" spread="7.90"/>
                    <measurement group_id="O2" value="12.47" spread="6.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE positive cells, lesional chg(n=10.6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.69" spread="10.96"/>
                    <measurement group_id="O2" value="-3.95" spread="20.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE positive cells,non-lesional D1 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.82" spread="10.21"/>
                    <measurement group_id="O2" value="16.59" spread="9.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE positive cells,non-lesional D85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.80" spread="11.66"/>
                    <measurement group_id="O2" value="18.30" spread="7.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE positive cells,non-lesional Chng (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.87" spread="9.83"/>
                    <measurement group_id="O2" value="-0.84" spread="6.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Correlation of Change From Baseline in IgE Receptor FceRI With Change From Baseline in UAS7 at Week 12 by Treatment, Skin Layer and Lesion Status</title>
        <description>Correlation of primary endpoint with The UAS7 which is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease.</description>
        <time_frame>Baseline through Day 85</time_frame>
        <population>Efficacy analysis set: Includes all randomized patients who received at least one dose of study drug and have post-randomization efficacy data.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Correlation of Change From Baseline in IgE Receptor FceRI With Change From Baseline in UAS7 at Week 12 by Treatment, Skin Layer and Lesion Status</title>
          <description>Correlation of primary endpoint with The UAS7 which is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease.</description>
          <population>Efficacy analysis set: Includes all randomized patients who received at least one dose of study drug and have post-randomization efficacy data.</population>
          <units>correlation coefficient</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dermis, lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3305"/>
                    <measurement group_id="O2" value="-0.1889"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermis, non-lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2785"/>
                    <measurement group_id="O2" value="0.5057"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Epidermis, lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0021"/>
                    <measurement group_id="O2" value="0.0101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Epidermis, non-lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0644"/>
                    <measurement group_id="O2" value="0.1563"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Correlation of Change From Baseline in IgE on Positive Skin Cells With Change From Baseline in UAS7 at Week 12 by Treatment, Skin Layer and Lesion Status</title>
        <description>Correlation of primary endpoint with The UAS7 which is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease.</description>
        <time_frame>Baseline through Day 85</time_frame>
        <population>Efficacy analysis set: Includes all randomized patients who received at least one dose of study drug and have post-randomization efficacy data.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Correlation of Change From Baseline in IgE on Positive Skin Cells With Change From Baseline in UAS7 at Week 12 by Treatment, Skin Layer and Lesion Status</title>
          <description>Correlation of primary endpoint with The UAS7 which is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease.</description>
          <population>Efficacy analysis set: Includes all randomized patients who received at least one dose of study drug and have post-randomization efficacy data.</population>
          <units>correlation coefficient</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dermis, lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4841"/>
                    <measurement group_id="O2" value="-0.0952"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermis, non-lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2759"/>
                    <measurement group_id="O2" value="0.4947"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Epidermis, lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2190"/>
                    <measurement group_id="O2" value="-0.1142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Epidermis, non-lesional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1574"/>
                    <measurement group_id="O2" value="-0.2310"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Observed Values and Absolute Change From Baseline in Skin Cell Subsets (CD3, CD4, CD8, Eosinophils, DCs, and Mast Cells) by Parameter, Skin Layer, Lesion Status, Treatment and Visit</title>
        <description>The average number of cells derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
        <time_frame>Baseline to Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis. Day 29 was an optional sampling time point in this paramter. The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>Dosed every 4 weeks up to 12 weeks</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Dosed every 4 weeks up to 12 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Values and Absolute Change From Baseline in Skin Cell Subsets (CD3, CD4, CD8, Eosinophils, DCs, and Mast Cells) by Parameter, Skin Layer, Lesion Status, Treatment and Visit</title>
          <description>The average number of cells derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis. Day 29 was an optional sampling time point in this paramter. The values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</population>
          <units># positive cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CD11c Epidermis Non lesional Baseline (n= 19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" spread="1.077"/>
                    <measurement group_id="O2" value="1.25" spread="0.584"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.41" spread="1.313"/>
                    <measurement group_id="O2" value="0.95" spread="0.920"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional D 8(n=18,10) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="1.351"/>
                    <measurement group_id="O2" value="-0.30" spread="1.255"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional D 29(n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional D 29(n=4,0) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.70" spread="0.383"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional D 85(n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.19" spread="0.806"/>
                    <measurement group_id="O2" value="0.53" spread="0.544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional D 85(n=17,8) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="1.216"/>
                    <measurement group_id="O2" value="-0.84" spread="0.524"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional D 140(n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.25" spread="1.630"/>
                    <measurement group_id="O2" value="0.58" spread="0.942"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis Non lesional D 140(n=17,7) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="1.216"/>
                    <measurement group_id="O2" value="-0.75" spread="0.939"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional baseline (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.17" spread="1.363"/>
                    <measurement group_id="O2" value="3.79" spread="8.028"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D8 (n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.63" spread="1.425"/>
                    <measurement group_id="O2" value="1.19" spread="1.329"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D8 (n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="1.153"/>
                    <measurement group_id="O2" value="-2.74" spread="8.466"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D29 (n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.56" spread="1.609"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D29 (n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="1.677"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D85 (n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" spread="0.577"/>
                    <measurement group_id="O2" value="0.46" spread="0.378"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D85 (n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="1.234"/>
                    <measurement group_id="O2" value="-4.06" spread="9.384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D140 (n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.555"/>
                    <measurement group_id="O2" value="0.18" spread="0.171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Epidermis lesional D140 (n=6,5) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.599"/>
                    <measurement group_id="O2" value="-6.37" spread="11.503"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.86" spread="7.322"/>
                    <measurement group_id="O2" value="22.97" spread="12.248"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.33" spread="8.971"/>
                    <measurement group_id="O2" value="20.22" spread="10.861"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D8 (n=19,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread="7.613"/>
                    <measurement group_id="O2" value="-2.75" spread="6.149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.63" spread="10.636"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D29 (n=4,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="15.472"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.05" spread="5.656"/>
                    <measurement group_id="O2" value="23.73" spread="19.031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D85 (n=17,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.52" spread="7.562"/>
                    <measurement group_id="O2" value="-1.23" spread="15.514"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D140 (n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.85" spread="11.189"/>
                    <measurement group_id="O2" value="15.58" spread="9.691"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis non lesional D140 (n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.51" spread="11.162"/>
                    <measurement group_id="O2" value="-11.51" spread="15.849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.14" spread="12.552"/>
                    <measurement group_id="O2" value="22.46" spread="9.700"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.85" spread="22.240"/>
                    <measurement group_id="O2" value="22.12" spread="8.669"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D8(n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.56" spread="16.705"/>
                    <measurement group_id="O2" value="0.99" spread="8.677"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D29 (n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.04" spread="11.509"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D29 (n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.28" spread="5.403"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D85 (n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.82" spread="13.724"/>
                    <measurement group_id="O2" value="22.59" spread="16.719"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D85 (n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="15.000"/>
                    <measurement group_id="O2" value="4.07" spread="22.288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D140 (n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.33" spread="21.229"/>
                    <measurement group_id="O2" value="22.59" spread="16.719"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis lesional D140 (n=6,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.30" spread="23.485"/>
                    <measurement group_id="O2" value="12.43" spread="9.210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.593"/>
                    <measurement group_id="O2" value="0.68" spread="1.151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.49" spread="0.754"/>
                    <measurement group_id="O2" value="0.34" spread="0.422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 8 (n=18,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.636"/>
                    <measurement group_id="O2" value="-0.34" spread="1.091"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.32" spread="0.367"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 29 (n=4,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.094"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" spread="0.660"/>
                    <measurement group_id="O2" value="0.30" spread="0.283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 85 (n=17,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.438"/>
                    <measurement group_id="O2" value="-0.46" spread="1.249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 140 (n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.36" spread="0.470"/>
                    <measurement group_id="O2" value="0.75" spread="1.245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis non lesional Day 140 (n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.554"/>
                    <measurement group_id="O2" value="-0.09" spread="2.092"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Baseline (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread="0.459"/>
                    <measurement group_id="O2" value="0.49" spread="0.892"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.55" spread="0.561"/>
                    <measurement group_id="O2" value="0.84" spread="0.913"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 8(n=11,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.604"/>
                    <measurement group_id="O2" value="0.11" spread="1.058"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.438"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 29(n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.33" spread="0.574"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" spread="0.558"/>
                    <measurement group_id="O2" value="0.47" spread="0.499"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 85(n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.672"/>
                    <measurement group_id="O2" value="-0.09" spread="0.873"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 140(n=7,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.84" spread="0.983"/>
                    <measurement group_id="O2" value="0.94" spread="0.969"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Epidermis lesional Day 140(n=7,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.843"/>
                    <measurement group_id="O2" value="0.98" spread="0.642"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Baseline(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.97" spread="4.924"/>
                    <measurement group_id="O2" value="12.46" spread="7.954"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 8(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.81" spread="5.359"/>
                    <measurement group_id="O2" value="8.66" spread="4.495"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 8(n=18,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" spread="6.503"/>
                    <measurement group_id="O2" value="-3.80" spread="5.984"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 29(n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.87" spread="1.427"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 29(n=4,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.78" spread="3.096"/>
                    <measurement group_id="O2" value="NA">no observaions made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 85(n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.71" spread="9.845"/>
                    <measurement group_id="O2" value="11.46" spread="7.900"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 85(n=18,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.61" spread="8.287"/>
                    <measurement group_id="O2" value="-2.09" spread="5.865"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 140(n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.80" spread="6.960"/>
                    <measurement group_id="O2" value="7.22" spread="5.823"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis non lesional Day 140(n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="5.717"/>
                    <measurement group_id="O2" value="-6.15" spread="10.618"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.75" spread="6.934"/>
                    <measurement group_id="O2" value="11.94" spread="6.245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Day 8 (n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.93" spread="8.543"/>
                    <measurement group_id="O2" value="12.56" spread="8.894"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Day 8 (n=11,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.07" spread="6.576"/>
                    <measurement group_id="O2" value="1.58" spread="7.177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Day 29 (n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.08" spread="7.275"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional day 29 (n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" spread="10.054"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Day 85 (n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.01" spread="3.615"/>
                    <measurement group_id="O2" value="14.44" spread="13.122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Day 85 (n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" spread="5.775"/>
                    <measurement group_id="O2" value="2.24" spread="13.351"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Day 140 (n=7,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.42" spread="7.600"/>
                    <measurement group_id="O2" value="14.58" spread="19.403"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD3 Dermis lesional Day 140(n=7,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="10.179"/>
                    <measurement group_id="O2" value="6.33" spread="20.884"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.99" spread="1.400"/>
                    <measurement group_id="O2" value="1.07" spread="1.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.20" spread="1.428"/>
                    <measurement group_id="O2" value="1.46" spread="1.639"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Day 8 (n=18,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="1.287"/>
                    <measurement group_id="O2" value="0.39" spread="1.826"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Day 29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.43" spread="1.144"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Day 29 (n=4,0) change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.922"/>
                    <measurement group_id="O2" value="NA">no observations made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Day 85(n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="1.528"/>
                    <measurement group_id="O2" value="0.44" spread="0.360"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epdiermis non lesional Day 85(n=18,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.31" spread="2.239"/>
                    <measurement group_id="O2" value="-0.49" spread="0.797"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Day 140(n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" spread="0.742"/>
                    <measurement group_id="O2" value="0.76" spread="1.355"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis non lesional Day 140(n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="1.283"/>
                    <measurement group_id="O2" value="-0.04" spread="1.802"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.95" spread="1.066"/>
                    <measurement group_id="O2" value="0.91" spread="1.204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Day 8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="0.725"/>
                    <measurement group_id="O2" value="0.90" spread="0.920"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Day 8(n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.46" spread="1.193"/>
                    <measurement group_id="O2" value="-0.04" spread="0.680"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.52" spread="1.927"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epdiermis lesional Day 29(n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="1.726"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.691"/>
                    <measurement group_id="O2" value="0.47" spread="0.432"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Day 85(n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.20" spread="0.847"/>
                    <measurement group_id="O2" value="-0.78" spread="1.3489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Day 140(n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.082"/>
                    <measurement group_id="O2" value="0.84" spread="0.518"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Epidermis lesional Day 140(n=6,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.61" spread="1.281"/>
                    <measurement group_id="O2" value="-0.73" spread="1.473"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Baseline(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.81" spread="6.868"/>
                    <measurement group_id="O2" value="19.39" spread="13.966"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 8(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.80" spread="8.144"/>
                    <measurement group_id="O2" value="16.04" spread="10.590"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 8(n=18,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" spread="9.816"/>
                    <measurement group_id="O2" value="-3.35" spread="10.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 29(n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.58" spread="5.070"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 29(n=4,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.88" spread="1.928"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 85(n=18,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.33" spread="7.741"/>
                    <measurement group_id="O2" value="19.21" spread="10.316"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 85(n=17,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.94" spread="10.126"/>
                    <measurement group_id="O2" value="-2.32" spread="9.451"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 140(n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.14" spread="11.300"/>
                    <measurement group_id="O2" value="16.90" spread="10.151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis non lesional Day 140(n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.36" spread="11.994"/>
                    <measurement group_id="O2" value="-2.01" spread="13.600"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.28" spread="5.351"/>
                    <measurement group_id="O2" value="18.98" spread="9.361"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.84" spread="10.403"/>
                    <measurement group_id="O2" value="17.74" spread="9.230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 8(n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.86" spread="7.576"/>
                    <measurement group_id="O2" value="0.10" spread="10.085"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.12" spread="8.146"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 29(n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.20" spread="4.250"/>
                    <measurement group_id="O2" value="NA">no ondervation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.20" spread="6.815"/>
                    <measurement group_id="O2" value="19.80" spread="12.617"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 85(n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.41" spread="7.859"/>
                    <measurement group_id="O2" value="0.98" spread="10.706"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 140(n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.81" spread="10.305"/>
                    <measurement group_id="O2" value="19.80" spread="12.617"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD4 Dermis lesional Day 140(n=6,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" spread="11.073"/>
                    <measurement group_id="O2" value="-0.15" spread="11.300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Baseline(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.306"/>
                    <measurement group_id="O2" value="0.24" spread="0.420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 8(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="0.593"/>
                    <measurement group_id="O2" value="0.20" spread="0.340"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 8(n=18,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.550"/>
                    <measurement group_id="O2" value="-0.04" spread="0.532"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 29(n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="0.347"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 29(n=4,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="0.448"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 85(n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.361"/>
                    <measurement group_id="O2" value="0.15" spread="0.207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 85(n=17,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.473"/>
                    <measurement group_id="O2" value="-0.13" spread="0.354"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 140(n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.215"/>
                    <measurement group_id="O2" value="0.28" spread="0.351"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis non lesional Day 140(n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.344"/>
                    <measurement group_id="O2" value="-0.01" spread="0.566"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.644"/>
                    <measurement group_id="O2" value="0.14" spread="0.207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.43" spread="0.568"/>
                    <measurement group_id="O2" value="0.08" spread="0.140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 8(n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.30" spread="0.534"/>
                    <measurement group_id="O2" value="-0.11" spread="0.236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.346"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 29(n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.363"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.313"/>
                    <measurement group_id="O2" value="0.03" spread="0.076"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 85(n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.356"/>
                    <measurement group_id="O2" value="-0.15" spread="0.235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 140(n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.082"/>
                    <measurement group_id="O2" value="0.33" spread="0.239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Epidermis lesional Day 140(n=6,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.53" spread="1.129"/>
                    <measurement group_id="O2" value="0.18" spread="0.304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Baseline(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.74" spread="3.278"/>
                    <measurement group_id="O2" value="6.59" spread="3.826"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 8(n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.10" spread="5.020"/>
                    <measurement group_id="O2" value="5.50" spread="3.779"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 8 (n=18,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.19" spread="4.798"/>
                    <measurement group_id="O2" value="-1.09" spread="1.374"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 29(n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.45" spread="5.369"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 29(n=4,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.80" spread="1.849"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 85 (n=18,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.51" spread="3.725"/>
                    <measurement group_id="O2" value="7.62" spread="4.288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 85 (n=17,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.46" spread="2.757"/>
                    <measurement group_id="O2" value="0.35" spread="3.067"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 140(n=17,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.30" spread="2.357"/>
                    <measurement group_id="O2" value="5.09" spread="3.523"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 140(n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.74" spread="2.726"/>
                    <measurement group_id="O2" value="-2.65" spread="1.686"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis lesional Baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.67" spread="2.983"/>
                    <measurement group_id="O2" value="4.63" spread="2.448"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.55" spread="4.953"/>
                    <measurement group_id="O2" value="6.12" spread="3.847"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 8(n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.02" spread="5.174"/>
                    <measurement group_id="O2" value="0.88" spread="2.679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.14" spread="6.133"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 29(n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.48" spread="5.639"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.19" spread="3.022"/>
                    <measurement group_id="O2" value="6.70" spread="6.690"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 85(n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.98" spread="3.556"/>
                    <measurement group_id="O2" value="1.48" spread="6.628"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 140(n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.73" spread="6.774"/>
                    <measurement group_id="O2" value="6.37" spread="10.549"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD8 Dermis non lesional Day 140(n=6,4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.87" spread="7.440"/>
                    <measurement group_id="O2" value="3.57" spread="10.671"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.47" spread="5.070"/>
                    <measurement group_id="O2" value="10.99" spread="4.498"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.29" spread="4.555"/>
                    <measurement group_id="O2" value="9.68" spread="3.057"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 8 (n=18,10) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.99" spread="5.511"/>
                    <measurement group_id="O2" value="-1.31" spread="2.493"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.00" spread="4.578"/>
                    <measurement group_id="O2" value="NA">no observationmade</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 29 (n=4,0) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="2.996"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.75" spread="4.492"/>
                    <measurement group_id="O2" value="9.17" spread="2.550"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 85 (n=17,8) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.62" spread="5.338"/>
                    <measurement group_id="O2" value="-1.02" spread="4.166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 140 (n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.89" spread="3.427"/>
                    <measurement group_id="O2" value="8.01" spread="2.744"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis non lesional Day 140 (n=16,7) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.023" spread="3.866"/>
                    <measurement group_id="O2" value="-2.43" spread="2.234"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.64" spread="3.710"/>
                    <measurement group_id="O2" value="10.18" spread="3.804"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.25" spread="5.742"/>
                    <measurement group_id="O2" value="10.84" spread="3.865"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 8(n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" spread="4.315"/>
                    <measurement group_id="O2" value="1.42" spread="5.978"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.06" spread="4.272"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 29(n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.74" spread="4.844"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.68" spread="6.160"/>
                    <measurement group_id="O2" value="8.77" spread="2.606"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 85(n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.10" spread="5.703"/>
                    <measurement group_id="O2" value="-0.97" spread="3.885"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 140(n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.88" spread="4.399"/>
                    <measurement group_id="O2" value="8.66" spread="2.136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Epidermis lesional Day 140(n=6,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.41" spread="3.792"/>
                    <measurement group_id="O2" value="-0.98" spread="3.444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.59" spread="6.616"/>
                    <measurement group_id="O2" value="10.11" spread="2.910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.00" spread="6.370"/>
                    <measurement group_id="O2" value="9.20" spread="3.319"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 8 (n=18,10) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.49" spread="5.924"/>
                    <measurement group_id="O2" value="-0.91" spread="3.078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.08" spread="2.062"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 29 (n=4,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.47" spread="2.968"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.93" spread="6.046"/>
                    <measurement group_id="O2" value="11.18" spread="4.568"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 85 (n=17,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="5.750"/>
                    <measurement group_id="O2" value="0.52" spread="3.239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 140(n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.05" spread="4.212"/>
                    <measurement group_id="O2" value="7.22" spread="2.100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis non lesional Day 140 (n=16,7) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="5.439"/>
                    <measurement group_id="O2" value="-3.79" spread="2.284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Baseline(n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.00" spread="4.570"/>
                    <measurement group_id="O2" value="7.31" spread="2.468"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 8(n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.15" spread="6.629"/>
                    <measurement group_id="O2" value="8.08" spread="2.743"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 8(n=11,8) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.60" spread="4.374"/>
                    <measurement group_id="O2" value="1.26" spread="2.890"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.42" spread="5.175"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 29(n=5,0) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.39" spread="5.412"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.07" spread="6.023"/>
                    <measurement group_id="O2" value="9.51" spread="2.891"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 85(n=10,6) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.11" spread="5.917"/>
                    <measurement group_id="O2" value="3.03" spread="2.659"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 140(n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.92" spread="6.704"/>
                    <measurement group_id="O2" value="8.87" spread="4.017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD117 Dermis lesional Day 140(n=6,4) Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.12" spread="6.410"/>
                    <measurement group_id="O2" value="2.88" spread="4.907"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 8 (n=18,10) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 29 (n=4,0) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 85 (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 140(n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis non lesional Day 140(n=17,8) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Baseline (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.03" spread="0.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 8 (n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 8 (n=11,8) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="-0.03" spread="0.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 29(n=5,0 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 29(n=5,0 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 85 (n=10,6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 85 (n=10,5) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="-.04" spread="0.089"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 140(n=6,5 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="1.00" spread="2.236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis lesional Day 140(n=6,4 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="1.25" spread="2.500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Baseline (n=19,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.91" spread="4.751"/>
                    <measurement group_id="O2" value="6.80" spread="8.610"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 8 (n=19,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.51" spread="4.142"/>
                    <measurement group_id="O2" value="4.47" spread="4.529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 8 (n=18,10 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.33" spread="5.141"/>
                    <measurement group_id="O2" value="-2.33" spread="4.750"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 29 (n=4,0 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.88" spread="1.876"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 29 (n=4,0 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.62" spread="1.811"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 85 (n=18,8 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.75" spread="3.397"/>
                    <measurement group_id="O2" value="5.28" spread="4.906"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 85 (n=17,8 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.34" spread="3.618"/>
                    <measurement group_id="O2" value="-2.16" spread="6.705"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 140 (n=18,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.69" spread="5.409"/>
                    <measurement group_id="O2" value="3.12" spread="3.120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis non lesional Day 140 (n=18,10 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.35" spread="5.078"/>
                    <measurement group_id="O2" value="-4.86" spread="7.348"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Baseline(n=19,8 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.29" spread="5.189"/>
                    <measurement group_id="O2" value="4.79" spread="5.931"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 8(n=11,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.71" spread="4.309"/>
                    <measurement group_id="O2" value="4.80" spread="4.512"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 8(n=11,8 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.75" spread="6.143"/>
                    <measurement group_id="O2" value="0.18" spread="3.394"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 29(n=5,0 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.09" spread="11.851"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 29(n=5,0 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.57" spread="12.812"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 85(n=10,6 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.96" spread="2.589"/>
                    <measurement group_id="O2" value="10.30" spread="15.647"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 85 (n=10,5 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.56" spread="7.155"/>
                    <measurement group_id="O2" value="6.36" spread="9.563"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 140(n=6,5 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.57" spread="2.589"/>
                    <measurement group_id="O2" value="9.44" spread="10.468"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis lesional Day 140 (n=6,4 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.20" spread="7.929"/>
                    <measurement group_id="O2" value="4.50" spread="5.073"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Baseline(n=19,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional day 8(n=19,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Day 8(n=18,10 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Day 29(n=4,0 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Day 29(n=4,0 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Day 85(n=17,8 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Day 85(n=16,8 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Day 140 (n=17,7 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis non lesional Day 140 (n=16,7 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Baseline(n=19,8 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 8(n=11,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 8(n=11,8 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 29(n=5,0 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 29(n=5,0 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 85(n=10,6 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 85(n=10,5 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 140(n=6,5 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Epidermis lesional Day 140(n=6,4 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Baseline(n=19,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 8(n=19,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.046"/>
                    <measurement group_id="O2" value="0.02" spread="0.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 8(n=18,10 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.047"/>
                    <measurement group_id="O2" value="0.02" spread="0.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 29(n=4,0 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 29(n=4,0 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 85(n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 85(n=16,8 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 140(n=17,7 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.03" spread="0.076"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis non lesional Day 140(n=16,7 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.03" spread="0.076"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Baseline(n=19,8 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.071"/>
                    <measurement group_id="O2" value="0.03" spread="0.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 8(n=11,10 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.129"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 8(n=11,8 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.159"/>
                    <measurement group_id="O2" value="-0.03" spread="0.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 29(n=5,0 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 29(n=5,0 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 85(n=10,6 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.03" spread="0.082"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 85(n=10,5 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.04" spread="0.089"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 140(n=6,5 )</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>H&amp;E Dermis lesional Day 140(n=6,4 ) Chge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.092"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day 8(n=18,10) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.094"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day 29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day 29 (n=4,0) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day 85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.103"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day 85(n=17,8) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.100"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day 140 (n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.097"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis non lesional Day140(n=16,7) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.100"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Baseline (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.046"/>
                    <measurement group_id="O2" value="0.08" spread="0.149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional day 8 (n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="1.085"/>
                    <measurement group_id="O2" value="0.10" spread="0.316"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Day 8 (n=11,8) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="1.093"/>
                    <measurement group_id="O2" value="0.05" spread="0.334"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Day 29 (n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.268"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Day 29 (n=5,0) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.179"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Day 85(n=10,6) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.063"/>
                    <measurement group_id="O2" value="-0.10" spread="0.167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Day 140 (n=7,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.000"/>
                    <measurement group_id="O2" value="0.00" spread="0.000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis lesional Day 140 (n=7,4) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.076"/>
                    <measurement group_id="O2" value="-0.10" spread="0.200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.55" spread="3.988"/>
                    <measurement group_id="O2" value="7.20" spread="3.045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 8 (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.14" spread="4.479"/>
                    <measurement group_id="O2" value="8.37" spread="2.305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 8 (n=18,10) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.14" spread="2.989"/>
                    <measurement group_id="O2" value="1.17" spread="3.030"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 29 (n=4,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.22" spread="4.981"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 29 (n=4,0) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" spread="4.816"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 85 (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.66" spread="4.076"/>
                    <measurement group_id="O2" value="8.33" spread="3.547"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 85 (n=17,8) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54" spread="3.753"/>
                    <measurement group_id="O2" value="1.35" spread="3.839"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 140 (n=17,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.77" spread="4.296"/>
                    <measurement group_id="O2" value="6.95" spread="1.812"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis non lesional Day 140 (n=16,7) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.27" spread="3.599"/>
                    <measurement group_id="O2" value="-0.62" spread="3.002"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Baseline (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.08" spread="3.764"/>
                    <measurement group_id="O2" value="6.41" spread="2.658"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 8 (n=11,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.19" spread="3.618"/>
                    <measurement group_id="O2" value="6.99" spread="3.451"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 8 (n=11,8) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="2.809"/>
                    <measurement group_id="O2" value="0.88" spread="2.998"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 29(n=5,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.20" spread="4.658"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 29(n=5,0) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.80" spread="3.023"/>
                    <measurement group_id="O2" value="NA">no observation made</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 85(n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.76" spread="3.082"/>
                    <measurement group_id="O2" value="6.93" spread="3.135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 85(n=10,6) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.39" spread="4.141"/>
                    <measurement group_id="O2" value="1.67" spread="2.047"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 140(n=7,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.59" spread="6.335"/>
                    <measurement group_id="O2" value="6.79" spread="1.635"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis lesional Day 140(n=7,4) Chg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.68" spread="6.641"/>
                    <measurement group_id="O2" value="1.97" spread="2.049"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Observed Values From Baseline Through End of Study of Serum Chemkines or Histamine in Peripheral Blood Cells by Parameter, Treatment and Visit</title>
        <time_frame>Baseline through Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Values From Baseline Through End of Study of Serum Chemkines or Histamine in Peripheral Blood Cells by Parameter, Treatment and Visit</title>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
          <units>ug/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Chemokine CCR3 Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9669" spread="2.31825"/>
                    <measurement group_id="O2" value="3.0394" spread="2.38102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CCR3 Day 2 (n=20, 10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8190" spread="2.94786"/>
                    <measurement group_id="O2" value="3.3035" spread="3.52023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CCR3 Day 8 (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5597" spread="2.22009"/>
                    <measurement group_id="O2" value="2.2742" spread="1.58648"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CCR3 Day 15 (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2711" spread="1.98781"/>
                    <measurement group_id="O2" value="2.0216" spread="1.46346"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CCR3 Day 29 (n=20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5869" spread="2.31661"/>
                    <measurement group_id="O2" value="2.2826" spread="1.56237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CCR3 Day 85 (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5178" spread="1.93931"/>
                    <measurement group_id="O2" value="1.8724" spread="1.16171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CCR3 Day 140 (n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.022" spread="2.44218"/>
                    <measurement group_id="O2" value="2.4060" spread="1.85351"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CXCR3/IP-10 Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1020" spread="0.07807"/>
                    <measurement group_id="O2" value="0.0638" spread="0.07208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CXCR3/IP-10 Day 2 (n=20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0836" spread="0.06630"/>
                    <measurement group_id="O2" value="0.0621" spread="0.06496"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CXCR3/IP-10 Day 8 (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0910" spread="0.07704"/>
                    <measurement group_id="O2" value="0.0772" spread="0.05990"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CXCR3/IP-10 Day 15 (n=19,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0883" spread="0.06303"/>
                    <measurement group_id="O2" value="0.0546" spread="0.02550"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CXCR3/IP-10 Day 29 (n=20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0881" spread="0.07624"/>
                    <measurement group_id="O2" value="0.0601" spread="0.04219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CXCR3/IP-10 Day 85 (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0714" spread="0.03079"/>
                    <measurement group_id="O2" value="0.0430" spread="0.02910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine CXCR3/IP-10 Day 140 (n=18,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0864" spread="0.07319"/>
                    <measurement group_id="O2" value="0.0859" spread="0.07489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histamine Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0526" spread="2.06757"/>
                    <measurement group_id="O2" value="5.2000" spread="1.13529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histamine Day 2 (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1500" spread="1.6111"/>
                    <measurement group_id="O2" value="5.0000" spread="1.76383"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histamine Day 8 (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5000" spread="2.01311"/>
                    <measurement group_id="O2" value="5.4000" spread="2.01108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histamine Day 15 (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5789" spread="1.64370"/>
                    <measurement group_id="O2" value="4.7500" spread="1.83225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histamine Day 29 (n=20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1500" spread="2.20705"/>
                    <measurement group_id="O2" value="4.7778" spread="3.38296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histamine Day 85 (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8235" spread="1.50977"/>
                    <measurement group_id="O2" value="5.0000" spread="1.30931"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Histamine Day 140 (n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8333" spread="2.64019"/>
                    <measurement group_id="O2" value="5.7000" spread="1.76698"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine ICAM-1 Baseline (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4858" spread="0.09955"/>
                    <measurement group_id="O2" value="0.5191" spread="0.14846"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine ICAM-1 Day 2 (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4468" spread="0.07872"/>
                    <measurement group_id="O2" value="0.4975" spread="0.14406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine ICAM-1 Day 8 (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4967" spread="0.12551"/>
                    <measurement group_id="O2" value="0.4728" spread="0.15713"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine ICAM-1 Day 15 (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4788" spread="0.12577"/>
                    <measurement group_id="O2" value="0.4709" spread="0.11789"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine ICAM-1 Day 29 (n=20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4633" spread="0.10172"/>
                    <measurement group_id="O2" value="0.4704" spread="0.11356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine ICAM-1 Day 85 ( n= 17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4314" spread="0.10424"/>
                    <measurement group_id="O2" value="0.4037" spread="0.05599"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemokine ICAM-1 Day 140 ( n=15,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4314" spread="0.10921"/>
                    <measurement group_id="O2" value="0.4918" spread="0.15250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Observed Values and Change From Baseline in Peripheral Blood Cell Subsets (FACS Parameters) at Week 12 (Day 85) by Treatment (PD Analysis Set) Measured as % Out of Leukocytes.</title>
        <description>Fluorescence-activated cell sorting (FACS) is a specialized type of flow cytometry that provides a method for sorting a heterogeneous mixture of biological cells into two or more containers, one cell at a time, based upon the specific light scattering and fluorescent characteristics of each cell. (FACS) provides fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. A wide range of fluorophores can be used as labels in flow cytometry. Fluorophores are typically attached to an antibody that recognizes a target feature on or in the cell; they may also be attached to a chemical entity with affinity for the cell membrane or another cellular structure. Each fluorophore has a characteristic peak excitation and emission wavelength.</description>
        <time_frame>Baseline through Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Values and Change From Baseline in Peripheral Blood Cell Subsets (FACS Parameters) at Week 12 (Day 85) by Treatment (PD Analysis Set) Measured as % Out of Leukocytes.</title>
          <description>Fluorescence-activated cell sorting (FACS) is a specialized type of flow cytometry that provides a method for sorting a heterogeneous mixture of biological cells into two or more containers, one cell at a time, based upon the specific light scattering and fluorescent characteristics of each cell. (FACS) provides fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. A wide range of fluorophores can be used as labels in flow cytometry. Fluorophores are typically attached to an antibody that recognizes a target feature on or in the cell; they may also be attached to a chemical entity with affinity for the cell membrane or another cellular structure. Each fluorophore has a characteristic peak excitation and emission wavelength.</description>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
          <units>% out of leukocytes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Basophils D1 (n=19,10) Units</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.132"/>
                    <measurement group_id="O2" value="0.36" spread="0.482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Basophils D85 (n=7,5) Units</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" spread="0.215"/>
                    <measurement group_id="O2" value="0.40" spread="0.451"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Basophils chge (n=7,5) Units</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.268"/>
                    <measurement group_id="O2" value="-0.06" spread="0.176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells bound IgE D1 (n=8,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.53" spread="5.001"/>
                    <measurement group_id="O2" value="15.19" spread="22.609"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells bound IgE D85(n=5,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.32" spread="7.579"/>
                    <measurement group_id="O2" value="25.66" spread="26.485"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells bound IgE chge (n=5,7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.46" spread="3.545"/>
                    <measurement group_id="O2" value="12.53" spread="21.725"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells D1 (n=10,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.57" spread="2.298"/>
                    <measurement group_id="O2" value="2.5" spread="1.247"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells D85 (n=7,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.84" spread="1.595"/>
                    <measurement group_id="O2" value="3.25" spread="2.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells Chge (n=7,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="1.377"/>
                    <measurement group_id="O2" value="0.73" spread="0.805"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dendritic cells D1 (n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.196"/>
                    <measurement group_id="O2" value="0.24" spread="0.140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dendritic cells D85 (n=8,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.231"/>
                    <measurement group_id="O2" value="0.27" spread="0.210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dendritic cells Chge (n=7,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.272"/>
                    <measurement group_id="O2" value="-0.02" spread="0.182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Observed Values and Change From Baseline in Peripheral Blood Cell Subsets (FACS Parameters) at Week 12 (Day 85) by Treatment (PD Analysis Set) Measured in Fluorescence Units.</title>
        <description>Fluorescence-activated cell sorting (FACS) is a specialized type of flow cytometry that provides a method for sorting a heterogeneous mixture of biological cells into two or more containers, one cell at a time, based upon the specific light scattering and fluorescent characteristics of each cell. (FACS) provides fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. A wide range of fluorophores can be used as labels in flow cytometry. Fluorophores are typically attached to an antibody that recognizes a target feature on or in the cell; they may also be attached to a chemical entity with affinity for the cell membrane or another cellular structure. Each fluorophore has a characteristic peak excitation and emission wavelength.</description>
        <time_frame>Baseline through Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.• FACS parameters: FceRI expression on basophils and IgE bound, FceR2 expression on B cells and IgE bound, and FceRI expression on dendritic cells</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Values and Change From Baseline in Peripheral Blood Cell Subsets (FACS Parameters) at Week 12 (Day 85) by Treatment (PD Analysis Set) Measured in Fluorescence Units.</title>
          <description>Fluorescence-activated cell sorting (FACS) is a specialized type of flow cytometry that provides a method for sorting a heterogeneous mixture of biological cells into two or more containers, one cell at a time, based upon the specific light scattering and fluorescent characteristics of each cell. (FACS) provides fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. A wide range of fluorophores can be used as labels in flow cytometry. Fluorophores are typically attached to an antibody that recognizes a target feature on or in the cell; they may also be attached to a chemical entity with affinity for the cell membrane or another cellular structure. Each fluorophore has a characteristic peak excitation and emission wavelength.</description>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.• FACS parameters: FceRI expression on basophils and IgE bound, FceR2 expression on B cells and IgE bound, and FceRI expression on dendritic cells</population>
          <units>Flourescence units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Basophils with FcεR1 exp D1 (n=11,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="292391" spread="135848"/>
                    <measurement group_id="O2" value="312038" spread="147037"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Basophils with FcεR1 exp D85 (n=7,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79457" spread="29333"/>
                    <measurement group_id="O2" value="291000" spread="108028"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Basophils with FcεR1 expression Chge (n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-243700" spread="118883"/>
                    <measurement group_id="O2" value="-38260" spread="60085"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Basophils with bound IgE D 1 (n=11,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="149656" spread="112936"/>
                    <measurement group_id="O2" value="236071" spread="89043"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Basophils with bound IgE D85 (n=7,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9554" spread="6214"/>
                    <measurement group_id="O2" value="212620" spread="109645"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Basophils with bound IgE Chge (n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-178487" spread="103456"/>
                    <measurement group_id="O2" value="-12680" spread="59998"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells with FcεR2 exp D1 (n=10,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59040" spread="42446"/>
                    <measurement group_id="O2" value="59700" spread="27171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells with FcεR2 exp D85 (n=7,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59429" spread="55980"/>
                    <measurement group_id="O2" value="49243" spread="33460"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD19+ B cells with FcεR2 exp chge (n=7,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12814" spread="32631"/>
                    <measurement group_id="O2" value="3986" spread="16779"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dendritic cells with FcεR1 expr D1 (n=10,7)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40880" spread="17191"/>
                    <measurement group_id="O2" value="43029" spread="12363"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dendritic cells with FcεR1 expr D85 (n=6,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38283" spread="5768"/>
                    <measurement group_id="O2" value="36962" spread="18562"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dendritic cells with FcεR1 expr Chge (n=5,5)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10100" spread="16887"/>
                    <measurement group_id="O2" value="-516" spread="5925"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of Baseline PD Parameters Between Healthy Volunteers and Urticaria Patients by Skin Layer Pharmacodynamic Analysis Set</title>
        <description>The # positive cell values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
        <time_frame>Baseline</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Healthy Subjects</title>
            <description>Baseline Value, healthy volunteers, no treatment applied</description>
          </group>
          <group group_id="O2">
            <title>Urticaria Patients</title>
            <description>All patients for study at baseline</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Baseline PD Parameters Between Healthy Volunteers and Urticaria Patients by Skin Layer Pharmacodynamic Analysis Set</title>
          <description>The # positive cell values are average of cell numbers derived from counting 5 consecutive microscopic fields. Area counted is 5x 0.196 mm2</description>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis</population>
          <units># positive cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CD11c Epidermis ( n= 10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1600" spread="1.13058"/>
                    <measurement group_id="O2" value="1.1241" spread="0.92944"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.6400" spread="9.31083"/>
                    <measurement group_id="O2" value="19.6207" spread="9.42260"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD11c All skin layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9000" spread="9.45983"/>
                    <measurement group_id="O2" value="10.3724" spread="11.44855"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 3 Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1600" spread="0.26331"/>
                    <measurement group_id="O2" value="0.4759" spread="0.82046"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cd 3 Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1600" spread="9.00311"/>
                    <measurement group_id="O2" value="10.8276" spread="6.11385"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 3 All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1600" spread="8.04634"/>
                    <measurement group_id="O2" value="5.6517" spread="6.77879"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 4 Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0250" spread="1.75804"/>
                    <measurement group_id="O2" value="1.0207" spread="1.26297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 4 Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.7750" spread="10.06565"/>
                    <measurement group_id="O2" value="17.7000" spread="9.72481"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 4 All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4000" spread="10.33004"/>
                    <measurement group_id="O2" value="9.3603" spread="10.86324"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 8 Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0600" spread="0.13499"/>
                    <measurement group_id="O2" value="0.2138" spread="0.34197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 8 Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9083" spread="4.07998"/>
                    <measurement group_id="O2" value="6.0322" spread="3.43255"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 8 All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9842" spread="4.11029"/>
                    <measurement group_id="O2" value="3.1230" spread="3.80226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 117 Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1600" spread="3.80386"/>
                    <measurement group_id="O2" value="9.9931" spread="4.85502"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 117 Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2200" spread="2.44849"/>
                    <measurement group_id="O2" value="10.4241" spread="5.56025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CD 117 All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1900" spread="3.26865"/>
                    <measurement group_id="O2" value="10.2086" spread="5.17814"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fc epsilon receptor I Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9800" spread="2.02309"/>
                    <measurement group_id="O2" value="6.0776" spread="3.12906"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fc epsilon receptor I Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2000" spread="6.76133"/>
                    <measurement group_id="O2" value="19.4500" spread="8.21582"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fc epsilon receptor I All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5900" spread="6.77968"/>
                    <measurement group_id="O2" value="12.7638" spread="9.13548"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000" spread="0.00000"/>
                    <measurement group_id="O2" value="0.0000" spread="0.00000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8000" spread="5.62929"/>
                    <measurement group_id="O2" value="6.8690" spread="6.19228"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Giemsa All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4000" spread="4.59061"/>
                    <measurement group_id="O2" value="3.4345" spread="5.55324"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Haematoxylin + Eosin Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000" spread="0.00000"/>
                    <measurement group_id="O2" value="0.0000" spread="0.00000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Haematoxylin + Eosin Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000" spread="0.00000"/>
                    <measurement group_id="O2" value="0.0000" spread="0.00000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Haematoxylin + Eosin All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000" spread="0.00000"/>
                    <measurement group_id="O2" value="0.0000" spread="0.00000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0800" spread="0.13984"/>
                    <measurement group_id="O2" value="1.0603" spread="2.30385"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7600" spread="5.92231"/>
                    <measurement group_id="O2" value="14.7776" spread="9.84503"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE All Skin layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4200" spread="6.03739"/>
                    <measurement group_id="O2" value="7.9190" spread="9.90380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE + CD 11c Epidermis (n=10,28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000" spread="0.00000"/>
                    <measurement group_id="O2" value="0.0357" spread="0.12237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE + CD 11c Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9150" spread="1.29401"/>
                    <measurement group_id="O2" value="1.0115" spread="1.05290"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE+CD 11c All Layers (n=20,57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4575" spread="1.00672"/>
                    <measurement group_id="O2" value="0.5322" spread="0.89651"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE + Tryptase Epidermis (n=10,28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000" spread="0.00000"/>
                    <measurement group_id="O2" value="0.0000" spread="0.00000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE + Tryptase Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3000" spread="1.01215"/>
                    <measurement group_id="O2" value="0.8713" spread="0.79919"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgE + Tryptase All Skin Layers (n=20,57)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6500" spread="0.96437"/>
                    <measurement group_id="O2" value="0.4433" spread="0.71586"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Epidermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000" spread="0.00000"/>
                    <measurement group_id="O2" value="0.0000" spread="0.00000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase Dermis (n=10,29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6400" spread="3.53371"/>
                    <measurement group_id="O2" value="6.7741" spread="3.64713"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tryptase All Skin Layers (n=20,58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3200" spread="4.18539"/>
                    <measurement group_id="O2" value="3.3871" spread="4.26704"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Levels of Omalizumab</title>
        <description>Serum concentrations (ng/mL) of omalizumab by visit after the administration of omalizumab 300 mg every 4 weeks</description>
        <time_frame>Baseline through Day 85</time_frame>
        <population>PK analysis set which included all subjects who received at least one dose of study drug and had evaluable IGE025 concentrations.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Levels of Omalizumab</title>
          <description>Serum concentrations (ng/mL) of omalizumab by visit after the administration of omalizumab 300 mg every 4 weeks</description>
          <population>PK analysis set which included all subjects who received at least one dose of study drug and had evaluable IGE025 concentrations.</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13400" spread="4690"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30100" spread="7800"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 29</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17000" spread="5500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 57</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25000" spread="8640"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28800" spread="11400"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean (SD) Serum Total IgE Concentration From Baseline by Visit</title>
        <time_frame>Baseline through Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Mean (SD) Serum Total IgE Concentration From Baseline by Visit</title>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1 Mean (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1037" spread="2474"/>
                    <measurement group_id="O2" value="442" spread="580.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2 Mean (20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1152" spread="2539"/>
                    <measurement group_id="O2" value="447" spread="587.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8 Mean (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1970" spread="2992"/>
                    <measurement group_id="O2" value="449" spread="593.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 29 Mean (n=20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2160" spread="2688"/>
                    <measurement group_id="O2" value="462" spread="628.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 57 Mean (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2430" spread="3343"/>
                    <measurement group_id="O2" value="490" spread="648.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 85 Mean (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2222" spread="2931"/>
                    <measurement group_id="O2" value="475" spread="616.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean (SD) Serum Total IgE % Change From Baseline by Visit</title>
        <time_frame>Baseline through Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Mean (SD) Serum Total IgE % Change From Baseline by Visit</title>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
          <units>Percent Change from Baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 2 % Change (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.1" spread="20.08"/>
                    <measurement group_id="O2" value="0.2" spread="5.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8 % Change (n=19,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="174.7" spread="84.93"/>
                    <measurement group_id="O2" value="-1.5" spread="9.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 29 % Change (n=19,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="247.2" spread="121.81"/>
                    <measurement group_id="O2" value="-4.0" spread="12.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 57 % Change (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="247.8" spread="134.10"/>
                    <measurement group_id="O2" value="-4.4" spread="18.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 85 % Change (n=16,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="244.8" spread="138.28"/>
                    <measurement group_id="O2" value="-6.9" spread="24.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean (SD) Serum Free IgE Concentration From Baseline by Visit</title>
        <time_frame>Baseline through Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Mean (SD) Serum Free IgE Concentration From Baseline by Visit</title>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1 Mean (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1037" spread="2474"/>
                    <measurement group_id="O2" value="442" spread="580.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2 Mean (n= 20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.8" spread="34.27"/>
                    <measurement group_id="O2" value="111.5" spread="60.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8 Mean (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.306" spread="29.7698"/>
                    <measurement group_id="O2" value="112.169" spread="58.6525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 29 Mean (n=20,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.506" spread="40.5322"/>
                    <measurement group_id="O2" value="107.881" spread="60.1708"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 57 Mean (n=19,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.502" spread="39.5567"/>
                    <measurement group_id="O2" value="122.318" spread="51.1087"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 85 Mean (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.776" spread="41.5426"/>
                    <measurement group_id="O2" value="120.978" spread="50.6692"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean (SD) Serum Free IgE % Change From Baseline by Visit</title>
        <time_frame>Baseline through Day 85</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Mean (SD) Serum Free IgE % Change From Baseline by Visit</title>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
          <units>% change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 2 % Change (n=19,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-96.166" spread="2.9216"/>
                    <measurement group_id="O2" value="-60.475" spread="17.9330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 8 % Change (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-96.446" spread="2.0162"/>
                    <measurement group_id="O2" value="-60.804" spread="15.8379"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 29 % Change (n=19,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-93.363" spread="3.5975"/>
                    <measurement group_id="O2" value="-61.456" spread="17.2340"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 57 % Change (n=18,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-94.460" spread="3.0681"/>
                    <measurement group_id="O2" value="-61.270" spread="18.6447"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 85 % Change (n=16,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-94.750" spread="3.420"/>
                    <measurement group_id="O2" value="-61.906" spread="17.7819"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Summary Statistics of Observed Values and Absolute Change From Baseline in Specific IgE Against Allergens and Bacterial Antigens by Parameter, Treatment and Visit</title>
        <time_frame>Baseline through Day 140</time_frame>
        <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Summary Statistics of Observed Values and Absolute Change From Baseline in Specific IgE Against Allergens and Bacterial Antigens by Parameter, Treatment and Visit</title>
          <population>All subjects who received at least one dose of study drug and had evaluable pharmacodynamic (PD) data were included in the PD data analysis.</population>
          <units>IU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Alternaria alternara Baseline (n= 0, 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Specific IgE not observed</measurement>
                    <measurement group_id="O2" value="0.1360">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alternaria alternara Day 140 (n= 0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Specific IgE not observed</measurement>
                    <measurement group_id="O2" value="0.1140">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Artemisia vulgaris (Mugwort) Baseline (n=1,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2730">one patient only tested positive</measurement>
                    <measurement group_id="O2" value="1.4800">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Artemisia vulgaris (Mugwort) Day 140( n=0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Specific IgE not observed</measurement>
                    <measurement group_id="O2" value="1.9100">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cat dander Basseline (n=3,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.9677" spread="22.73833"/>
                    <measurement group_id="O2" value="0.6980">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cat dander Day 140 (n=2,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.0100" spread="26.14881"/>
                    <measurement group_id="O2" value="0.8980">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common silver Birch Baseline (n=6,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3640" spread="19.48667"/>
                    <measurement group_id="O2" value="12.3767" spread="11.22609"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common silver Birch Day 140 (n=4,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4890" spread="6.15938"/>
                    <measurement group_id="O2" value="14.8600" spread="16.58164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dog dander Baseline (n=2,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.7720" spread="37.09199"/>
                    <measurement group_id="O2" value="0.5120">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dog dander Day 140 (n=1,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.1000">one patient only tested positive</measurement>
                    <measurement group_id="O2" value="0.6690">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermatophagoides farinae Baseline (n=3,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3333" spread="3.39883"/>
                    <measurement group_id="O2" value="0.4340">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermatophagoides farinae Day 140 (n=2,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3200" spread="0.89095"/>
                    <measurement group_id="O2" value="0.4970">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermatophagoides pteronyssinus Baseline (n=5,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1250" spread="1.46791"/>
                    <measurement group_id="O2" value="0.4550">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermatophagoides pteronyssinus Day 140(n=4,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2463" spread="3.72052"/>
                    <measurement group_id="O2" value="0.5170">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grey Alder (t2) Baseline (n=4,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.7650" spread="20.03961"/>
                    <measurement group_id="O2" value="10.9533" spread="10.92027"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grey Alder (t2) Day 140(n=3,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4900" spread="5.16654"/>
                    <measurement group_id="O2" value="13.0533" spread="15.24029"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>German Cockroach Baseline (n=4,2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8605" spread="0.93609"/>
                    <measurement group_id="O2" value="0.4425" spread="0.62579"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>German Cockroach Day 140 (n=4,2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0263" spread="2.87190"/>
                    <measurement group_id="O2" value="0.4705" spread="0.66539"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hazelnut Baseline (n=3,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.9627" spread="14.49722"/>
                    <measurement group_id="O2" value="7.3267" spread="8.28160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hazelnut Day 140 (n=2,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4450" spread="1.50977"/>
                    <measurement group_id="O2" value="8.9927" spread="10.59244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Olive (black, fresh) Baseline (n=4,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0890" spread="0.17800"/>
                    <measurement group_id="O2" value="0.0000">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Olive (black, fresh) Day 140 (n=3,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1037" spread="0.17956"/>
                    <measurement group_id="O2" value="0.0000">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platanus acerifolia Baseline (n=1,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1210">one patient only tested positive</measurement>
                    <measurement group_id="O2" value="3.7100">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platanus acerifolia Day 140 (n=0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000">one patient only tested positive</measurement>
                    <measurement group_id="O2" value="4.8300">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parietaria judaica Baseline(n=0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000">one patient only tested positive</measurement>
                    <measurement group_id="O2" value="1.4900">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parietaria judaica Day 140 (n=0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0000">one patient only tested positive</measurement>
                    <measurement group_id="O2" value="2.0000">one patient only tested positive</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin A Baseline (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7264" spread="3.07821"/>
                    <measurement group_id="O2" value="0.0741" spread="0.13580"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin A Day 140 (n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6161" spread="4.39936"/>
                    <measurement group_id="O2" value="0.1077" spread="0.15294"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin C Baseline (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8976" spread="3.02621"/>
                    <measurement group_id="O2" value="0.1626" spread="0.27226"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin C Day 140 (n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1089" spread="4.19834"/>
                    <measurement group_id="O2" value="0.1922" spread="0.28071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin TSST Baseline (n=20,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5390" spread="1.02581"/>
                    <measurement group_id="O2" value="0.1537" spread="0.23902"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin TSST Day 140 (n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8402" spread="1.05356"/>
                    <measurement group_id="O2" value="0.1468" spread="0.22155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alternaria alternara Absolute Change (n = 0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Specific IgE not observed</measurement>
                    <measurement group_id="O2" value="-0.0220">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Artemisia vulgaris Absolute Change (n = 0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Specific IgE not observed</measurement>
                    <measurement group_id="O2" value="0.4300">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cat dander Absolute Change (n = 2,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1315" spread="4.33951"/>
                    <measurement group_id="O2" value="0.2000">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Silver Birch Absolute Change (n = 4,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.2145" spread="26.47094"/>
                    <measurement group_id="O2" value="2.4833" spread="5.63479"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dog dander Absolute Change (n = 1,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9000">only 1 observation</measurement>
                    <measurement group_id="O2" value="0.1570">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermatophagoides farinae Absolute Change(n=2,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9350" spread="1.46371"/>
                    <measurement group_id="O2" value="0.0630">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dermatophagoides pteronyssinus Abs Chge (n=4,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6800" spread="3.05938"/>
                    <measurement group_id="O2" value="0.0620">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grey Alder Absolute Change(n=3,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-12.6300" spread="27.47614"/>
                    <measurement group_id="O2" value="2.1000" spread="4.50900"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>German Cockroach Absolute Change(n=4,2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1658" spread="2.03436"/>
                    <measurement group_id="O2" value="0.0280" spread="0.03960"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hazelnut Absolute Change(n=2,3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.83000" spread="18.15850"/>
                    <measurement group_id="O2" value="1.6660" spread="2.47183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Olive (black, fresh) Absolute Change(n=3,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0150" spread="0.02598"/>
                    <measurement group_id="O2" value="0.0000">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platanus acerifolia Absolute Change(n=0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Specific IgE not observed</measurement>
                    <measurement group_id="O2" value="1.1200">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Parietaria judaica Absolute Change(n=0,1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Specific IgE not observed</measurement>
                    <measurement group_id="O2" value="0.5100">only 1 observation</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin A Abs chge (n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8090" spread="2.63582"/>
                    <measurement group_id="O2" value="0.0336" spread="0.09116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin C Abs chge (n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1116" spread="2.26524"/>
                    <measurement group_id="O2" value="0.0296" spread="0.06545"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Staphylococcal enterotoxin TSST Abs chge(n=18,10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2608" spread="0.72963"/>
                    <measurement group_id="O2" value="-0.0069" spread="0.15669"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Urticaria Activity Score (UAS7)</title>
        <description>Efficacy was assessed by the urticaria activity score (UAS). UAS was completed each morning and evening on a daily basis to record patient symptoms of itch and hives via an electronic diary. The UAS is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease. A negative change score (Week 12 score minus Baseline score) indicates improvement.</description>
        <time_frame>Baseline, Day 85</time_frame>
        <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data. If the Week 12 value was missing, it was imputed as the last available UAS7 value (LOCF).</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Urticaria Activity Score (UAS7)</title>
          <description>Efficacy was assessed by the urticaria activity score (UAS). UAS was completed each morning and evening on a daily basis to record patient symptoms of itch and hives via an electronic diary. The UAS is a composite eDiary−recorded score with numeric severity intensity ratings on a scale of 0−3 (0 = none to 3 = intense/severe) for 1) the number of wheals (hives); and 2) the intensity of the itch. The daily UAS is the average of the morning and evening scores and the UAS7 is the sum of the daily UAS scores over 7 days.UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. If fewer than 7 but at least 4 daily values were non-missing, the remaining values were imputed to be the average. This is equivalent to multiplying the average of the non missing values by 7. UAS7 score: The sum of the daily UAS scores over 7 days. Range: 0-42. A higher score indicates worse disease. A negative change score (Week 12 score minus Baseline score) indicates improvement.</description>
          <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data. If the Week 12 value was missing, it was imputed as the last available UAS7 value (LOCF).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-23.1" spread="12.94" lower_limit="-28.5" upper_limit="-17.6"/>
                    <measurement group_id="O2" value="-8.1" spread="14.45" lower_limit="-17.8" upper_limit="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Likert Scale-Physician’s and Patients In-clinic Global Assessment by Treatment</title>
        <description>The investigator or the person he or she designated and the patient provided scoring of the patient’s global assessment of symptoms (urticaria lesions (hives) and pruritus) reflective of the patient’s condition over the 12 hours prior to the visit (0 = no symptoms, 1 = mild, 2 = moderate 3 = severe</description>
        <time_frame>Baseline, Day 85</time_frame>
        <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Likert Scale-Physician’s and Patients In-clinic Global Assessment by Treatment</title>
          <description>The investigator or the person he or she designated and the patient provided scoring of the patient’s global assessment of symptoms (urticaria lesions (hives) and pruritus) reflective of the patient’s condition over the 12 hours prior to the visit (0 = no symptoms, 1 = mild, 2 = moderate 3 = severe</description>
          <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physicians Baseline (n=17,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.87"/>
                    <measurement group_id="O2" value="2.2" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Physicians Week 12, (day 85) (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="1.01"/>
                    <measurement group_id="O2" value="2.0" spread="1.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients Baseline (n=17,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.87"/>
                    <measurement group_id="O2" value="2.4" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients Week 12, (day 85) (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.05"/>
                    <measurement group_id="O2" value="1.9" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Angioedema-free Days Weeks 4 Through 12 by Treatment</title>
        <time_frame>Day 29 to Day 85</time_frame>
        <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Angioedema-free Days Weeks 4 Through 12 by Treatment</title>
          <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
          <units>Percentage of days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9" spread="22.83" lower_limit="87.8" upper_limit="94.0"/>
                    <measurement group_id="O2" value="70.5" spread="28.50" lower_limit="64.9" upper_limit="76.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Dermatology Life Quality Index (DLQI) by Treatment</title>
        <description>The DLQI is a 10-item dermatology-specific health-related quality of life measure. Patients rated their dermatology symptoms as well as the impact of their skin condition on various aspects of their lives. An overall score was calculated as well as for the following domains: Symptoms and Feelings, Daily Activities, Leisure, Work and School, Personal Relationships, Treatment.Negative score shows positive efficacy. Meaning of DLQI Scores 0-1 = no effect at all on patient's life 2-5 = small effect on patient's life 6-10 = moderate effect on patient's life 11-20 = very large effect on patient's life 21-30 = extremely large effect on patient's life. The DLQI is calculated by summing the score of each question resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired. The DLQI can also be expressed as a percentage of the maximum possible score of 30.</description>
        <time_frame>Baseline through Day 85</time_frame>
        <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Dermatology Life Quality Index (DLQI) by Treatment</title>
          <description>The DLQI is a 10-item dermatology-specific health-related quality of life measure. Patients rated their dermatology symptoms as well as the impact of their skin condition on various aspects of their lives. An overall score was calculated as well as for the following domains: Symptoms and Feelings, Daily Activities, Leisure, Work and School, Personal Relationships, Treatment.Negative score shows positive efficacy. Meaning of DLQI Scores 0-1 = no effect at all on patient's life 2-5 = small effect on patient's life 6-10 = moderate effect on patient's life 11-20 = very large effect on patient's life 21-30 = extremely large effect on patient's life. The DLQI is calculated by summing the score of each question resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired. The DLQI can also be expressed as a percentage of the maximum possible score of 30.</description>
          <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
          <units>Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.19" spread="8.159"/>
                    <measurement group_id="O2" value="-3.13" spread="7.180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Skindex-29 by Treatment</title>
        <description>The Skindex-29 is a validated 29-item instrument to measure the effects of skin disease on patients’ quality of life.Results are reported as 3 scale scores (functioning, emotions and symptoms) and a composite score (average scale score). The domain scores and the overall score are expressed on a 100-point scale, with higher scores indicating a lower level of quality of life. The cuttoff values for each category are noted below. Symtoms; 39 mild, 42 moderate,52 severe. Emotions; 24 mild, 35 moderate, 39 severe. Functioning: 21 mild, 32 moderate, 37 severe. Overal Score: 25 mild, 32 moderate, 44 severe.</description>
        <time_frame>Baseline and Day 85</time_frame>
        <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Skindex-29 by Treatment</title>
          <description>The Skindex-29 is a validated 29-item instrument to measure the effects of skin disease on patients’ quality of life.Results are reported as 3 scale scores (functioning, emotions and symptoms) and a composite score (average scale score). The domain scores and the overall score are expressed on a 100-point scale, with higher scores indicating a lower level of quality of life. The cuttoff values for each category are noted below. Symtoms; 39 mild, 42 moderate,52 severe. Emotions; 24 mild, 35 moderate, 39 severe. Functioning: 21 mild, 32 moderate, 37 severe. Overal Score: 25 mild, 32 moderate, 44 severe.</description>
          <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
          <units>Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (n= 16,9)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.98" spread="7.807"/>
                    <measurement group_id="O2" value="21.67" spread="9.068"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 85 (n=16,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.17" spread="7.119"/>
                    <measurement group_id="O2" value="22.63" spread="10.276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chronic Urticaria Quality of Life Questionnaire (Cu-Q2OL) by Treatment</title>
        <description>The Cu-Q2OL is a 23-item CIU-specific health-related quality of life questionnaire. Patients rated their CIU symptoms and the impact of their CIU on various aspects of their lives. An overall score was calculated as well for the following domains: pruritus, swelling, impact on life activities, sleep problems, limits, and looks. Zero is the minmum score and 100 the maximum score. The higher score correlates to more disease activity.</description>
        <time_frame>Baseline and Day 85</time_frame>
        <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
        <group_list>
          <group group_id="O1">
            <title>IGE025</title>
            <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
          <group group_id="O2">
            <title>Placebo IGE025</title>
            <description>Placebo IGE025 administered subcutaneously every 4 weeks at the study center</description>
          </group>
        </group_list>
        <measure>
          <title>Chronic Urticaria Quality of Life Questionnaire (Cu-Q2OL) by Treatment</title>
          <description>The Cu-Q2OL is a 23-item CIU-specific health-related quality of life questionnaire. Patients rated their CIU symptoms and the impact of their CIU on various aspects of their lives. An overall score was calculated as well for the following domains: pruritus, swelling, impact on life activities, sleep problems, limits, and looks. Zero is the minmum score and 100 the maximum score. The higher score correlates to more disease activity.</description>
          <population>Efficacy analysis set which included all randomized patients who received at least one dose of study drug and had post-randomization efficacy data</population>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (n=16,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.71" spread="19.881"/>
                    <measurement group_id="O2" value="59.24" spread="15.350"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 85 (n=17,8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.51" spread="22.319"/>
                    <measurement group_id="O2" value="53.53" spread="29.817"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year 5 mos</time_frame>
      <group_list>
        <group group_id="E1">
          <title>IGE025 300mg</title>
          <description>IGE025 administered subcutaneously every 4 weeks at the study center</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo administered subcutaneously every 4 weeks at the study center.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Tongue pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fractured coccyx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Fungal test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia areata</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Novartis Pharmaceuticals</organization>
      <phone>862-778-8300</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

